Management of Cbd Stones Final

download Management of Cbd Stones Final

of 64

Transcript of Management of Cbd Stones Final

  • 8/8/2019 Management of Cbd Stones Final

    1/64

    BY SURGERY UNIT II

    PROFESSOR:DR.K.VENKATESH

    ASST PROFESSORS:DR.PURNAIAH

    DR.N.V.N. REDDY

    DR.GEETA

    POST GRADUATES:DR SYAM BABU

    DR .K.RADHA KRISHNA

    DR.KALYAN

  • 8/8/2019 Management of Cbd Stones Final

    2/64

    INCIDENCEy CBD stones are found in 10-15% of patients with

    cholelithiasis.

    y Incidence increases with age.

  • 8/8/2019 Management of Cbd Stones Final

    3/64

    TYPESy Two types

    y 1.Primary -formed in bile duct(brown pigment)

    y 2.Secondary-form in the gall bladder-migratethrough cystic duct-enter the CBD

    Two types:a)cholesterol (75%)

    b)black pigment(25%)

  • 8/8/2019 Management of Cbd Stones Final

    4/64

    CLINICAL FEATURESyAsymptomatic(15-20%)

    y Recurrent bouts of biliary colic accompanied by

    intermittent jaundicey Episodic upper abdominal pain and dyspepsia

    y Stone impaction with progressive jaundice

    y Cholangitis(CHARCOTS TRIAD,REYNOLDS

    PENTAD)

    y Gall stone pancreatitis

    y Secondary biliary cirrhosis and portal hypertension

  • 8/8/2019 Management of Cbd Stones Final

    5/64

    LAB INVESTIGATIONSy Serum bilirubin, serum aminotranferases,alkaline

    phosphatase-elevated in pts with biliary obstruction-

    neither sensitive nor specific for CBD stones.y Elevated amylase and lipase-pancreatitis

    y Elevated WBC count-

    cholangitis,pancreatitis,associated cholecystitis

    y LFT can be normal in 1/3rd of patients with CBDstones.

  • 8/8/2019 Management of Cbd Stones Final

    6/64

    MANAGEMENTy Can be considered under 3 clinical circumstances in

    which patients who may have CBD stones are seen:

    y 1.PRIORTO CHOLECYSTECTOMYy 2.DURING CHOLECYSTECTOMY

    y 3.SOME TIME AFTER CHOLECYSTECTOMY

  • 8/8/2019 Management of Cbd Stones Final

    7/64

    PREOPERATIVEy Diagnosis of duct stones cannot be made based on

    history ,physical examination and lab investigations

    alone.

  • 8/8/2019 Management of Cbd Stones Final

    8/64

    ULTRASOUNDy TRANSCUTANEOUS ULTRASOUND

    y Gall stones

    y CBD diameter -no dilatation does not mean no

    stones(50%-no dilatation)-prevalence of duct stones is higher in ptswith dilated duct(>5mm) vs non dilatedduct (58% vs 1%)

    y CBD stones-sensitivity 50%(30-90%)

    y limitations:-operator dependant

    -gaseous distension of upper abdominal viscera

    -obese

    -following previous surgery

  • 8/8/2019 Management of Cbd Stones Final

    9/64

  • 8/8/2019 Management of Cbd Stones Final

    10/64

    CT SCANy Sensitivity-80%

    y Limitations

    y Exposure to radiation

  • 8/8/2019 Management of Cbd Stones Final

    11/64

    MRCPy This has emerged as the diagnostic alternative to ERCP for

    detection and exclusion of cholelithiasis.

    y

    Sensitivity 95%y PPV-95%,NPV-97%-thus useful in avoiding unnecessary

    diagnostic ERCP.

    y AVOIDS ERCP IN>50% OF PATIENTS.

    y Entire biliary tract can be imaged in a single breath-hold of 20sec

    y Can visualise upto 4th order intrahepatic bile ducts and candetect stones as small as 2mm.

    y Patients with positive MRCP Consider for more invasivetherapeutic procedures.

  • 8/8/2019 Management of Cbd Stones Final

    12/64

    MRCP

    y LIMITATIONS: 1.less resolution

    2.obesity decreases quality ofimages

    3.claustrophobia

    4.pts on pacemakers

    aneurysmal clips

  • 8/8/2019 Management of Cbd Stones Final

    13/64

  • 8/8/2019 Management of Cbd Stones Final

    14/64

    ENDOSCOPIC ULTRASOUND

    y Diagnostic accuracy -95% for CBD stones

    y Compared with ERCP-it is semi invasive,with almostno procedure related complications and negligible

    failure rate.

    y EUS prior to invasive diagnostic and therapeutic

    techniques would lower the rate of procedure relatedcomplications in patients suspected of having CBD

    stones.

  • 8/8/2019 Management of Cbd Stones Final

    15/64

  • 8/8/2019 Management of Cbd Stones Final

    16/64

    ERCPy ERCP(endoscopic retrograde

    cholangiopancreatography)

    yDiagnostic as well as therapeutic modality

    y Cannulation of ampulla and diagnostic

    cholangiography is possible in >90% of cases.

    y Sensitivity-90%

    y Specificity-98%

  • 8/8/2019 Management of Cbd Stones Final

    17/64

    ERCPy PROCEDURE

    y Sedation

    yProne position with head turned to side

    y Side viewing duodenoscope

    y Curved cannula into papilla of vater(difficult cannulation-

    in duodenal diverticulum,Billroth 2 GJ,Roux en Y GJ)

    ySmall amount of contrast-to confirm visualization ofdesired duct

    y Additional contrast-to define entire selected ductal

    system

  • 8/8/2019 Management of Cbd Stones Final

    18/64

  • 8/8/2019 Management of Cbd Stones Final

    19/64

  • 8/8/2019 Management of Cbd Stones Final

    20/64

  • 8/8/2019 Management of Cbd Stones Final

    21/64

    ERCPy CONTRAINDICATIONS TO ERCP

    y Uncooperative patient

    y Perforated viscusy Newly created esophageal,gastric or duodenal

    anastomosis.

    y RELATIVE CONTRAINDICATIONS

    yAcute pancreatitis(exacerbation)

    y Pancreatic pseudocyst(infection)

    yAllergy to iodinated contrast(anaphylaxis)

  • 8/8/2019 Management of Cbd Stones Final

    22/64

    ERCPy COMPLICATIONS:found to relate to five risk factors:

    1.sphincter of oddi dysfunction

    2.prescence of cirrhosis

    3.difficulty in cannulating bile duct

    4.use of precut sphincterotomy to access to bile

    duct

    5.combined percutaneous endoscopic procedure

    DIAGNOSTICERCP

    THERAPEUTICERCP

    MORBIDITY 3% 7%

    MORTALITY 0.2% 0.5%

  • 8/8/2019 Management of Cbd Stones Final

    23/64

    ERCPy COMPLICATIONS:

    y MC complication:Acute Pancreatitis(1% vs 5%)

    y Definition :serum amylase>3times ,24 hrs afterERCP ,requiring at least 2 days hospital stay.

    y Risk factors

    y How to minimize pancreatitis

    y Prophylaxis-?somatostatin,?IL-10,GTN

  • 8/8/2019 Management of Cbd Stones Final

    24/64

    ERCPy COMPLICATIONS:

    y Bleeding

    y Sepsis

    y Bowel perforationsy Cholecystitis

    y Cholangitis

    y Cardiopulmonary complications-arrythmias,hypoventilation,aspiration-leading cause ofdeath

    y Recurrent stones

    y Papillary stenosis

    y Liver abscess

  • 8/8/2019 Management of Cbd Stones Final

    25/64

    ERCPy DIAGNOSTIC ERCP-found CBD stones-endoscopic

    sphincterotomy-stones pass spontaneously or after

    irrigation of duct-if not passed-stone extraction withballoon catheter or dormia basket(80-90% extraction

    rate)

    y If stones are larger-use

    mechanical/electrohydraulic/laser/ESWL /largeballoon dilatation for stone extraction.

    y If stone impacted and could not be removed-pass a

    stent over a guidewire across the stone.

  • 8/8/2019 Management of Cbd Stones Final

    26/64

  • 8/8/2019 Management of Cbd Stones Final

    27/64

  • 8/8/2019 Management of Cbd Stones Final

    28/64

  • 8/8/2019 Management of Cbd Stones Final

    29/64

    LIMITATIONSy Mechanical lithotripsy-difficult to crush hard calcified

    stones

    yIntraductal shock wave lithotripsy-by lithotripsy probeunder cholangioscope guidance-risk of bile duct

    injury.

    y ESWL-fluoroscopic orUSG guidance-requires

    multiple sessions.

  • 8/8/2019 Management of Cbd Stones Final

    30/64

    PERCUTANEOUS TRANSHEPATIC

    CHOLANGIOGRAPHYy If ERCP not available

    y If ERCP not possible due to anatomic considerations

    y If ERCP not successfuly PROCEDURE:

    y Needle into intrahepatic bile ducts through skin-

    cholangiogram done-wire insertion-catheter over

    wire for external biliary drainage and access tobiliary system.

  • 8/8/2019 Management of Cbd Stones Final

    31/64

    PTCy PERCUTANEOUS TRANSHEPATIC ROUTE

    y Dormia basket

    y Transhepatic cholangioscopy and lithotripsyy Percutaneous choledochoscopy through

    transhepatic route or through T-tube tract.

  • 8/8/2019 Management of Cbd Stones Final

    32/64

    yAfter bile duct clearance is achieved by non

    operative methods ,cholecystectomy is

    recommended in younger patients to decrease therisk of future cholecystitis and recurrent biliary colic.

    y In high risk or elderly patients perform

    cholecystectomy as needed rather than

    prophylactically following non operative treatment of

    duct stones.

  • 8/8/2019 Management of Cbd Stones Final

    33/64

  • 8/8/2019 Management of Cbd Stones Final

    34/64

    INTRAOPERATIVEy When pts present to the operating room for

    cholecystectomy-3 situations can exist

    y

    1.Pts have CBD stones confirmed bypreoperative studies(ERCP,MRCP,EUS)

    y 2.Pts suspected to have CBD stones by clinical

    presentation,lab values,usg abdomen

    y 3.No suspicion of CBD stones.y 10-15% of patients undergoing laparoscopic

    cholecystectomy harbor CBD stones,only 15% go on

    to develop symptoms due to retained stones.

  • 8/8/2019 Management of Cbd Stones Final

    35/64

    INDICAT

    IONS FOR

    EXP

    LORAT

    ION OF CBDMadden provided good indicators for cholangiography or

    exploration of the duct in stone disease.

    Recent or present jaundice (cholangiography)

    Dilatation of the common bile duct (7 mmultrasonographically or 10 mm at direct visualization)(cholangiography)

    Multiple stones in the gallbladder together with a largecystic duct (cholangiography)

    Aspiration of murky bile from the duct (cholangiography)

    Presence of a palpable stone (exploration)

    Roentgenographic visualization of a stone (exploration)

    When in doubt, explore!

  • 8/8/2019 Management of Cbd Stones Final

    36/64

    INTRAOPERATIVE

    CHOLANGIOGRAPHYy Most commonly used method to detect CBD stones

    during surgery.

    y

    PROCEDUREy Place 14G catheter into the cystic duct

    transabdominally 3 cm medial to the midclavicular

    port and inject dye and inspect on fluoroscope.

    y The need for routine IOC is a matter of debate.

  • 8/8/2019 Management of Cbd Stones Final

    37/64

  • 8/8/2019 Management of Cbd Stones Final

    38/64

    INTRAOPERATIVE

    ULTRASOUNDADVANTAGES LIMITATIONS

    VERYSENSITIVE TESTANDEQUIVALENTTO INTRAOPERATIVE

    CHOLANGIOGRAM

    HIGH COST OF EQUIPMENT

    NO RISK OF CBD INJURY NEED FOR EXPERTISE

    WILLNOT CAUSE FALSE POSITIVE

    RESULTS OWING TO

    INTRODUCTION OF AIR INTO THE

    BILIARYTREE

    LEARNING CURVE

  • 8/8/2019 Management of Cbd Stones Final

    39/64

    y Once the presence of bile duct stone has been

    established at the time of surgery-the treatment

    options include

    y 1.Open or laparoscopic bile duct exploration

    y 2.Post cholecystectomy non operative techniques

    like ERCP orPTC.

  • 8/8/2019 Management of Cbd Stones Final

    40/64

    OPEN BILE DUCT

    EXPLORATIONy CBD opened in longitudinal direction

    y Bile duct is cleared of stones by using saline

    irrigation,fogarty balloon,stone forceps(Ex:DesJardinforceps) and scoops(Ex:Semm scoop) placed into

    the biliary tract through the opening.

    y Choledhocoscope is also used for stone removal

    under direct vision and also inspect the biliary tractfor any other pathology.

  • 8/8/2019 Management of Cbd Stones Final

    41/64

    LAPAROSCOPIC COMMON BILE

    DUCT EXPLORATION(LCBDE)y Techniques of laparoscopic ductal stone clearance

    include

    y

    1.Transcystic duct extractiony 2.Direct supraduodenal CBD exploration

    y 3.Laparoendoscopic approach

  • 8/8/2019 Management of Cbd Stones Final

    42/64

    TRANSCYSTIC DUCT

    EXTRACTIONy Indicated for small floating stones upto 7mm .

    y Two commonly used techniques

    y 1.the choledochoscopic visually guided methody 2.the radiologically guided wire basket trawling

    technique.

  • 8/8/2019 Management of Cbd Stones Final

    43/64

    TRANSCYSTIC DUCT

    EXTRACTIONy Cholangiogram

    y Guidewire into cystic duct

    y Mechanical or pneumatic dilator over wire

    y Choledochoscope insertion

    y Stone extraction

    y Completion cystic duct cholangiogram

    y Ligation of cystic duct

    y Cholecystectomy

    y Any doubt about residual fragments-insert cystic duct drainage

    cannulay Post op cholangiogram 24hrs after surgery

    y If normal-cannula capped

    y Pt discharged on 3rd pod

    y Cannula removed 10-14 days later.

  • 8/8/2019 Management of Cbd Stones Final

    44/64

  • 8/8/2019 Management of Cbd Stones Final

    45/64

  • 8/8/2019 Management of Cbd Stones Final

    46/64

  • 8/8/2019 Management of Cbd Stones Final

    47/64

    DIRECT SUPRADUODENAL

    CBD EXPLORATIONy Indicated for large >7mm and occluding stones,cystic duct

    diameter less than 4mm,cystic duct entrance either posterioror distal.

    y PROCEDURE

    y Choledochotomy-1cm or size of largest stone

    y Irrigation of CBD to flush out small stones and sludgefacilitated by iv glucagon administration.

    y Stone extraction with basket or choledhoscopic aidedextraction.

    y Completion cholangiogramy Biliary drainage through T-tube/cystic duct drainage cannula

    y Primary closure of choledochotomy decreased hospital stay

    y Alternative to T-tube ,a stent can be placed in anterogradefashion .

  • 8/8/2019 Management of Cbd Stones Final

    48/64

  • 8/8/2019 Management of Cbd Stones Final

    49/64

    CYSTIC DUCT DRAINAGE

    CANNULA

    T-TUBE

    POST OP CHOLANGIOGRAM-1ST

    POD

    7TH POD

    CANNULAREMOVAL-7TH POD 2 WEEKS

  • 8/8/2019 Management of Cbd Stones Final

    50/64

    ALTERNATIVES TO LAPAROSCOPIC

    OR OPEN CBD EXPLORATIONy Transcystic stent placement over a wire antegrade

    through sphincter of oddi at the time of

    cholecystectomy.

    y Intraoperative ERCP and stent placement.

    y Intraoperative vs postoperative ERCP.

    C S O S

  • 8/8/2019 Management of Cbd Stones Final

    51/64

    CBD STONES AFTER

    CHOLECYSTECTOMY

    y TWO TYPES

    y 1.Retained stones-2yrs after operation

  • 8/8/2019 Management of Cbd Stones Final

    52/64

    RETAINED STONESy Non surgical methods for removal of retained stones

    y 1.Flushing

    y 2.Dissolutiony 3.Percutaneous stone extraction via a T-tube

    tract(BURHENNE TECHNIQUE)

    y 4.endoscopic sphincterotomy and stone extraction

    y If above methods fail-surgical biliary drainageprocedures.

  • 8/8/2019 Management of Cbd Stones Final

    53/64

  • 8/8/2019 Management of Cbd Stones Final

    54/64

    RECURRENT STONESy Endoscopic sphincterotomy and stone extraction is

    the first line of treatment and surgery (open or

    laparoscopic)is reserved if this approach fails.

  • 8/8/2019 Management of Cbd Stones Final

    55/64

    SURGICAL BILIARY

    DRAINAGE PROCEDURESy INDICATIONS

    y 1.Multiple stones

    y2.Incomplete removal of all stones

    y 3.Impacted,irremovable distal bile duct stones

    y 4.Markedly dilated CBD

    y 5.Distal CBD obstruction fron tumor or stricture

    y 6.Reoccurance after previous CBD exploration.

  • 8/8/2019 Management of Cbd Stones Final

    56/64

    SURGICAL DRAINAGE

    PROCEDURESy 1.TRANS DUODENAL SPHINCTEROTOMY

    y 2.CHOLEDOCHODUODENOSTOMY

    yA)SIDE TO SIDE

    y B)END TO SIDE

    y 3.CHOLEDOCHOJEJUNOSTOMYS

  • 8/8/2019 Management of Cbd Stones Final

    57/64

    TRANSDUODENAL

    SPHINCTEROPLASTYINDICATIONS:

    1.Impacted ampullary stone

    2.Papillary stenosis

    3.Multiple stones,particularly in prescence of non dilated bile duct

    PROCEDURE

    - 2nd portion duodenum

    - 11 oclock incision

    - Cut and sew

    - Pancreatic duct @ 3 to 4

    oclock

    -Preserve duodenal lumen-COMPLICATIONS

    Pancreatitis:

    - Extensive manipulation

    - Electrocautery

    - Accidental suturing of

    pancreatic duct orifice

  • 8/8/2019 Management of Cbd Stones Final

    58/64

  • 8/8/2019 Management of Cbd Stones Final

    59/64

  • 8/8/2019 Management of Cbd Stones Final

    60/64

    CHOLEDOCHODUODENOSTOMYy TYPES:

    y 1.SIDE TO SIDE

    y 2.END TO SIDE

    y CBD diameter of atleast 12mm to create wide stomawhich ensures adequate drainage and prevents stenosis.

    y COMPLICATIONS

    y 1.Cholangitis

    y 2.Stenosis of stomay 3.Medical complications-pulmonary embolism,myocardial

    infarction

    y 4.SUMP syndrome.

  • 8/8/2019 Management of Cbd Stones Final

    61/64

  • 8/8/2019 Management of Cbd Stones Final

    62/64

    CHOEDOCHOJEJUNOSTOMYy Either with a loop of jejunum or using a Roux-en-Y

    configuration.

    y

    CDD vs CDJy CHOLEDOCHODUODENOSTOMY is preferred over

    CHOLEDOCHOJEJUNOSTOMY because both

    procedures have similar outcomes but it is easier to

    perform CDD than CDJ.CDJ also allows for easyendoscopic interventions if needed in future.

  • 8/8/2019 Management of Cbd Stones Final

    63/64

  • 8/8/2019 Management of Cbd Stones Final

    64/64

    CONCLUSIONy Multidisciplinary approach to CBD stones

    y Multiple treatment options are available so that

    treatment can be tailored to fit each individualsituation

    y Laparoscopic CBD exploration is safe and

    carries low morbidity and mortality rate.

    y Surgeon experience determines: Lap vs Open approach

    Type of drainage procedure if necessary